Cargando…
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
The rat parvovirus H-1PV has oncolytic and tumour-suppressive properties potentially exploitable in cancer therapy. This possibility is being explored and results are encouraging, but it is necessary to improve the oncotoxicity of the virus. Here we show that this can be achieved by co-treating canc...
Autores principales: | Li, Junwei, Bonifati, Serena, Hristov, Georgi, Marttila, Tiina, Valmary-Degano, Séverine, Stanzel, Sven, Schnölzer, Martina, Mougin, Christiane, Aprahamian, Marc, Grekova, Svitlana P, Raykov, Zahari, Rommelaere, Jean, Marchini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799578/ https://www.ncbi.nlm.nih.gov/pubmed/24092664 http://dx.doi.org/10.1002/emmm.201302796 |
Ejemplares similares
-
Parvoviruses-tools to fine-tune anticancer immune responses
por: Grekova, Svitlana P., et al.
Publicado: (2012) -
TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells
por: Raykov, Zahari, et al.
Publicado: (2013) -
Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015) -
Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells
por: Grekova, Svitlana P., et al.
Publicado: (2011) -
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
por: Kulkarni, Amit, et al.
Publicado: (2021)